In 2011, the Bohn lab mentioned antinociception towards both equally chemically induced and inflammation-derived discomfort, and experiments indicated deficiency of opioid receptor modulation, but were not able to define a selected goal. Moreover, the conolidine molecule did not interact with the classical receptors, meaning that it wouldn't contend towards https://andreshyrqg.blog5.net/73374304/conolidine-an-overview